Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL)
Stock · NASDAQ · Miscellaneous
$5.24as of 10/16/2026
Price chart
CUVL Signal Track Record
How signals performed across all stocks →What CUVL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| 200-Day Moving Average TouchActive now | 26 | -4.0% | 27% | July 17, 2026 |
| Bollinger Band Breakdown | 25 | +4.6% | 60% | July 31, 2026 |
| Bollinger Band Breakout | 20 | -5.2% | 30% | August 20, 2026 |
| Any 20-session window (baseline) | -1.5% | 43% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CUVL
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's p…
- Sector
- Miscellaneous
- Industry
- Miscellaneous
- Website
- www.clinuvel.com/
Fundamentals
- 1-day range
- $4.91$5.23
- Market cap
- $336.61M
- P/E (trailing)
- 11.33
- P/E (forward)
- —
- EPS (trailing)
- $0.67
- Dividend yield
- 0.29%
- Beta
- 0.24
- Avg. volume
- 13.3K
- Ex-dividend date
- September 8, 2026
- Dividend pay date
- September 28, 2026
Clinuvel Pharmaceuticals Limited American Depositary Shares Competitors
Chosen by industry and closest market cap.
- CUVLClinuvel Pharmaceuticals Limited American Depositary Shares$5.24▲ 3.56%Market cap $336.61MP/E 11.33$7.08$13.48
- DXSTDecent Holding Inc Class A Ordinary Shares$1.33▼ 20.83%Market cap $4.79MP/E —$1.5$1,550
- CDTGCDT Environmental Technology Investment Holdings Limited ordinary shares$1.03▼ 5.50%Market cap $4.71MP/E —$0.7296$18
- FERGFerguson Enterprises Inc. Common Stock$231.61▲ 1.25%Market cap $49.55BP/E 18.22$212.13$271.64
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares | $336.61M | 11.33 | $5.24 | ▲ 3.56% | $7.08$13.48 |
| DXST Decent Holding Inc Class A Ordinary Shares | $4.79M | — | $1.33 | ▼ 20.83% | $1.5$1,550 |
| CDTG CDT Environmental Technology Investment Holdings Limited ordinary shares | $4.71M | — | $1.03 | ▼ 5.50% | $0.7296$18 |
| FERG Ferguson Enterprises Inc. Common Stock | $49.55B | 18.22 | $231.61 | ▲ 1.25% | $212.13$271.64 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Top 3 Australian Biotech Stocks To Watch In October 2026Yahoo · 10/10/2026
- 3 Great Australian Biotech Stocks With P E Under 14Yahoo · 10/2/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
Clinuvel Included in List of Australian Biotech Stocks
Clinuvel was featured in a Yahoo Finance article highlighting three Australian biotech stocks with price-to-earnings ratios under 14. The company’s trailing P/E of 12.6 aligns with this valuation criterion. This inclusion places the stock in a comparative context for investors tracking low-multiple biotech names in the region.
Clinuvel Included in List of Australian Biotech Stocks. Clinuvel was featured in a Yahoo Finance article highlighting three Australian biotech stocks with price-to-earnings ratios under 14. The company’s trailing P/E of 12.6 aligns with this valuation criterion. This inclusion places the stock in a comparative context for investors tracking low-multiple biotech names in the region.